Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
No clinical results as the company provides digital health platforms rather than therapeutics. Their products are deployed in the Middle East and Africa to automate medical coding, claims review, telehealth, and clinical decision support using artificial intelligence. Recent partnership with GlobeMed Saudi to optimize healthcare benefits management through advanced AI technology. Supported by Microsoft, HSBC Bank, TiE, Area2071; part of WHO/ITU’s Ai4Health initiative. Estimated enterprise valuation $4–6 million as of Nov. 2021. Revenue growth reported but exact figures undisclosed. Company size estimated at ~11–50 employees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TachyHealth.